#71: Pharma firms must abide by 10 articles to avoid foundering in a sea of data🌊
gkesari.substack.com
Hello, This newsletter will take you about 4 minutes to read. I. Spotlight: Pharma firms must abide by 10 articles to avoid foundering in a sea of data🌊 The market size for artificial intelligence (AI) in the pharmaceutical industry is projected to reach USD9.24 billion by 2030. For most organizations, the chief data officer (CDO) is at the helm of this spending on data and analytics (D&A). The role of CDOs has been steadily evolving and expanding over the past decade, with
#71: Pharma firms must abide by 10 articles to avoid foundering in a sea of data🌊
#71: Pharma firms must abide by 10 articles…
#71: Pharma firms must abide by 10 articles to avoid foundering in a sea of data🌊
Hello, This newsletter will take you about 4 minutes to read. I. Spotlight: Pharma firms must abide by 10 articles to avoid foundering in a sea of data🌊 The market size for artificial intelligence (AI) in the pharmaceutical industry is projected to reach USD9.24 billion by 2030. For most organizations, the chief data officer (CDO) is at the helm of this spending on data and analytics (D&A). The role of CDOs has been steadily evolving and expanding over the past decade, with